TAZ/YAP reprogram cellular energetics to promote the dependence of breast cancer cell growth on exogenous Gln, and TAZ/YAP induced GOT1 and phosphoserine aminotransferase (PSAT1) expression to promote the conversion of Gln to α-KG, and then to support cell growth (14). The gene discussed is PSAT1; the disease is breast carcinoma.